Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,738,340 | 3,537,999 | 3,652,090 | 4,021,764 | 3,931,594 |
| Marketable Securities | 132,521 | 1,727,152 | 2,955,506 | 4,619,269 | 4,417,409 |
| Receivables | 9,816,614 | 9,245,717 | 9,650,176 | 11,233,600 | 8,883,649 |
| Inventories | 7,394,644 | 7,230,706 | 6,838,962 | 6,937,132 | 6,901,575 |
| Other current assets | 75,722 | 76,086 | 94,536 | 75,955 | 91,403 |
| TOTAL | $21,157,840 | $21,817,660 | $23,191,270 | $26,887,720 | $24,225,630 |
| Non-Current Assets | |||||
| PPE Net | 11,336,180 | 11,352,030 | 11,219,980 | 11,157,640 | 10,844,440 |
| Investments And Advances | 1,453,939 | 1,619,364 | 1,482,729 | 1,445,658 | 1,690,335 |
| Intangibles | 28,312,686 | 28,716,122 | 26,842,123 | 28,189,061 | 27,855,474 |
| Other Non-Current Assets | 11,024,445 | 10,692,624 | 10,660,218 | 9,365,131 | 9,835,241 |
| TOTAL | $52,127,250 | $52,380,140 | $50,205,050 | $50,157,490 | $50,225,490 |
| Total Assets | $73,285,100 | $74,197,800 | $73,396,320 | $77,045,200 | $74,451,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,248,229 | 3,317,350 | 3,499,091 | 6,130,754 | 7,413,684 |
| Accounts payable and accrued liabilities | 17,978,620 | 18,540,890 | 19,708,350 | 19,725,250 | 17,468,050 |
| Accrued Expenses | 922,595 | 913,032 | 621,950 | 362,047 | 681,142 |
| Other current liabilities | 2,527,986 | 2,395,441 | 2,377,093 | 2,125,446 | 2,118,553 |
| TOTAL | $25,677,420 | $25,166,710 | $26,206,480 | $28,343,500 | $27,681,430 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,135,530 | 19,219,320 | 18,913,500 | 20,245,540 | 19,473,910 |
| Other Non-Current Liabilities | 12,561,686 | 12,626,474 | 11,912,509 | 11,884,265 | 11,293,946 |
| TOTAL | $30,228,560 | $32,255,390 | $31,274,140 | $32,727,310 | $31,545,410 |
| Total Liabilities | $55,905,980 | $57,422,110 | $57,480,620 | $61,070,810 | $59,226,840 |
| Shareholders' Equity | |||||
| Common Shares | 1,701,311 | 1,709,399 | 1,676,777 | 1,706,433 | 1,687,831 |
| Retained earnings | 10,832,600 | 10,062,370 | 9,004,592 | 8,882,820 | 8,035,978 |
| Other shareholders' equity | 463,198 | 602,356 | 941,632 | 1,017,782 | 1,180,726 |
| TOTAL | $17,379,120 | $16,775,700 | $15,915,700 | $15,974,390 | $15,224,280 |
| Total Liabilities And Equity | $73,285,100 | $74,197,810 | $73,396,320 | $77,045,200 | $74,451,120 |